Publications by authors named "Joseph D Fullerton"

Claim this Profile
D
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
Neil J Press, Roger J Taylor, Joseph D Fullerton, Pamela Tranter, Clive McCarthy

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate.
Neil J Press, Roger J Taylor, Joseph D Fullerton, Pamela Tranter, Clive McCarthy

J Med Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective xanthine-based inhibitors of phosphodiesterase 5.
Nichola J Arnold, Ruth Arnold, David Beer, Gurdip Bhalay, Stephen P Collingwood, Joseph D Fullerton

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential.
Neil J Press, Roger J Taylor, Joseph D Fullerton, Pamela Tranter, Clive McCarthy

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis